Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Silent Manipulation of Mental Health Treatment Recommendations from a Large Language Model.

medRxiv : the preprint server for health sciences·2026

Same author

Author AI Disclosure in JAMA Network Journal Submissions-Reply.

JAMA·2026

Same author

Ambient AI and Measurement Bias in Psychiatric Notes-Reply.

JAMA psychiatry·2026

Same author

Emulated trial of artificial intelligence use and subsequent depressive outcomes in a survey of US adults.

BMJ mental health·2026

Same author

Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Same author

Correction: A brain-enriched circRNA blood biomarker can predict response to SSRI antidepressants.

Molecular psychiatry·2026

Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026

Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026

Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026

Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026

Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026

Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Effective agents in treating mania.

¹Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.

The Journal of Clinical Psychiatry

|May 1, 2009

Summary

This summary is machine-generated.

New research on bipolar mania treatments shows that while many drugs are effective, they differ significantly in side effects. Choosing the best medication requires balancing efficacy with patient safety and tolerability.

Related Experiment Videos

Last Updated: Jun 23, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

Psychiatry
Pharmacology
Clinical Medicine

Background:

Recent guidelines from the American Psychiatric Association have prompted extensive research into bipolar mania pharmacotherapy.
Numerous pharmaceutical agents are available for treating bipolar mania.

Purpose of the Study:

To review the efficacy and side effect profiles of pharmaceutical agents for bipolar mania.
To inform clinical decision-making regarding the optimal selection of medications for individual patients.

Main Methods:

Meta-analyses of existing studies on bipolar mania medications.
Comparative analysis of efficacy rates and side effect profiles.

Main Results:

Multiple medications demonstrate efficacy in treating bipolar mania.
Efficacy rates among effective treatments are comparable.
Significant variations exist in the side effect profiles of these medications.

Conclusions:

Clinicians must weigh efficacy against safety and tolerability when prescribing for bipolar mania.
Personalized treatment selection is crucial for managing bipolar disorder effectively.